Boston Precision Neurotherapeutics
- Transcranial Magnetic Stimulation (TMS)
- Neurofeedback Therapy
- Ketamine Therapy
- Erectile Dysfunction (ED) Treatment
Natick, MA
Natick has multiple clinics offering neurofeedback therapy, a form of EEG based biofeedback that trains the brain using real time electrical activity feedback. Neurofeedback is FDA cleared for relaxation and stress management, and many Natick providers also market it for ADHD, anxiety, PTSD, sleep, concussion recovery, and peak performance. Those secondary claims sit beyond the FDA cleared indications and are considered off label, with Emerging evidence in ADHD and anxiety and weaker evidence elsewhere. Providers typically include licensed psychologists, LPCs, and mental health professionals, and the de facto quality standard is Board Certification in Neurofeedback (BCIA). A reputable Natick clinic will start with a QEEG brain map to establish a baseline, set symptom based goals rather than vague optimization promises, and frame expectations realistically across a 20 session protocol. Massachusetts does not license neurofeedback as a standalone profession, so scope depends on the provider's underlying credential. Cost and commitment vary widely, which makes careful vetting essential before signing up for a multi thousand dollar package.
Regulatory context
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
The Massachusetts Board of Registration in Medicine investigates TMS clinics for supervision deficiencies and off-label marketing. Massachusetts has a strong corporate practice of medicine doctrine and a well-developed academic medical community, so TMS is often offered through hospital-affiliated clinics with rigorous protocols. The Massachusetts attorney general has pursued Chapter 93A actions against neurofeedback providers making cure claims. Commercial insurers, including Blue Cross Blue Shield of Massachusetts, require documented treatment-resistant depression before covering TMS.
Explore related care